• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞色素P450 3A:基因多态性与种族间差异

Cytochrome P450 3A: genetic polymorphisms and inter-ethnic differences.

作者信息

Krishna D R, Shekar M S

机构信息

Drug Metabolism, Cancer and Aging Research Lab, Department of Pharmacology, University College of Pharmaceutical Sciences, Kakatiya University, Warangal, Andhra Pradesh, India.

出版信息

Methods Find Exp Clin Pharmacol. 2005 Oct;27(8):559-67. doi: 10.1358/mf.2005.27.8.928310.

DOI:10.1358/mf.2005.27.8.928310
PMID:16273136
Abstract

Ethnicity is a demographic variable that plays an important role in interindividual variability of drug metabolism and response. The genetic variations of drug-metabolizing enzymes exhibiting interindividual differences of drug metabolism also show differences between populations. The reason for this is that the frequency of a polymorphism is found to differ between populations. The other reason is that different variants are seen in different populations. Most drugs are biotransformed in the body by cytochrome P450. The CYP3A isozymes are responsible for the metabolism of 50-60% of all currently prescribed drugs. Studies have shown that there is variability in CYP3A activity and also inter-ethnic differences in CYP3A-mediated drug metabolism. The purpose of this review is to focus on the genetic polymorphism and ethnic variations in CYP3A-mediated oxidative drug metabolism.

摘要

种族是一个人口统计学变量,在药物代谢和反应的个体间变异性中起重要作用。表现出药物代谢个体差异的药物代谢酶的基因变异在不同人群之间也存在差异。原因在于,一种多态性的频率在不同人群中有所不同。另一个原因是在不同人群中可见不同的变异体。大多数药物在体内通过细胞色素P450进行生物转化。CYP3A同工酶负责目前所有处方药中50%-60%的代谢。研究表明,CYP3A活性存在变异性,并且在CYP3A介导的药物代谢中也存在种族间差异。本综述的目的是聚焦于CYP3A介导的氧化药物代谢中的基因多态性和种族差异。

相似文献

1
Cytochrome P450 3A: genetic polymorphisms and inter-ethnic differences.细胞色素P450 3A:基因多态性与种族间差异
Methods Find Exp Clin Pharmacol. 2005 Oct;27(8):559-67. doi: 10.1358/mf.2005.27.8.928310.
2
CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation.实体器官移植中的CYP3A基因多态性与免疫抑制药物
Expert Rev Mol Diagn. 2009 May;9(4):383-90. doi: 10.1586/erm.09.11.
3
Polymorphism of human cytochrome P450 enzymes and its clinical impact.人类细胞色素P450酶的多态性及其临床影响。
Drug Metab Rev. 2009;41(2):89-295. doi: 10.1080/03602530902843483.
4
Genetic factors for individual administration of immunosuppressants in organ transplantation.器官移植中免疫抑制剂个体化给药的遗传因素。
Hepatobiliary Pancreat Dis Int. 2006 Aug;5(3):337-44.
5
[Clinical significance of cytochrome P450 genetic polymorphism--part IV. Cytochrome P450 3A4 and 3A5].细胞色素P450基因多态性的临床意义——第四部分。细胞色素P450 3A4和3A5
Ceska Slov Farm. 2011 Dec;60(6):276-82.
6
Cytochrome P450 3A, NADPH cytochrome P450 reductase and cytochrome b5 in the upper airways in horse.马的上呼吸道中的细胞色素P450 3A、NADPH细胞色素P450还原酶和细胞色素b5。
Res Vet Sci. 2008 Aug;85(1):80-5. doi: 10.1016/j.rvsc.2007.09.012. Epub 2007 Nov 5.
7
Drug-metabolizing enzyme inhibition by ketoconazole does not reduce interindividual variability of CYP3A activity as measured by oral midazolam.酮康唑对药物代谢酶的抑制作用,并不会降低口服咪达唑仑所测定的CYP3A活性的个体间变异性。
Drug Metab Dispos. 2006 Dec;34(12):2079-82. doi: 10.1124/dmd.106.011742. Epub 2006 Sep 22.
8
Novel genetic biomarkers for susceptibility to oral submucous fibrosis: cytochrome P450 3A.口腔黏膜下纤维性变易感性的新型遗传生物标志物:细胞色素 P450 3A。
Med Hypotheses. 2011 Nov;77(5):834-6. doi: 10.1016/j.mehy.2011.07.049. Epub 2011 Sep 14.
9
Genetic polymorphisms in CYP3A5 and MDR1 genes and their correlations with plasma levels of tacrolimus and cyclosporine in renal transplant recipients.肾移植受者中CYP3A5和MDR1基因的遗传多态性及其与他克莫司和环孢素血药浓度的相关性
Transplant Proc. 2009 Apr;41(3):840-2. doi: 10.1016/j.transproceed.2009.01.050.
10
Understanding the genetic causes of inter-patient variability. Clinical relevance with focus on cardiovascular drugs.
Rom J Intern Med. 2007;45(4):313-9.

引用本文的文献

1
Species Differences in the Biotransformation of Aflatoxin B1: Primary Determinants of Relative Carcinogenic Potency in Different Animal Species.黄曲霉毒素B1生物转化中的物种差异:不同动物物种相对致癌潜力的主要决定因素
Toxins (Basel). 2025 Jan 9;17(1):30. doi: 10.3390/toxins17010030.
2
Treating asthma in the time of COVID.在新冠疫情期间治疗哮喘。
J Allergy Clin Immunol. 2023 Apr;151(4):809-817. doi: 10.1016/j.jaci.2022.12.800. Epub 2022 Dec 14.
3
Potent Inhibition of Human Cytochrome P450 3A4 by Biflavone Components from Ginkgo Biloba and Selaginella Tamariscina.
银杏和卷柏中的双黄酮成分对人细胞色素P450 3A4的强效抑制作用。
Front Pharmacol. 2022 Feb 28;13:856784. doi: 10.3389/fphar.2022.856784. eCollection 2022.
4
Effects of Polymorphisms on Drug Addiction Risk Among the Chinese Han Population.中国汉族人群中多态性对药物成瘾风险的影响。
Front Public Health. 2019 Nov 19;7:315. doi: 10.3389/fpubh.2019.00315. eCollection 2019.
5
Urinary 6β-Hydroxycortisol/Cortisol Ratio Most Highly Correlates With Midazolam Clearance Under Hepatic CYP3A Inhibition and Induction in Females: A Pharmacometabolomics Approach.尿 6β-羟基皮质醇/皮质醇比值与女性肝 CYP3A 抑制和诱导下咪达唑仑清除率的相关性最高:一种基于药代代谢组学的方法。
AAPS J. 2016 Sep;18(5):1254-1261. doi: 10.1208/s12248-016-9941-y. Epub 2016 Jun 17.
6
CYP3A4*1B polymorphism and cancer risk: a HuGE review and meta-analysis.CYP3A4*1B基因多态性与癌症风险:一项HuGE综述与荟萃分析
Tumour Biol. 2013 Apr;34(2):649-60. doi: 10.1007/s13277-012-0592-z. Epub 2012 Nov 20.
7
Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus.糖尿病患者肝脏中细胞色素 P450 3A4 的表达和活性显著降低。
Br J Pharmacol. 2011 Jul;163(5):937-47. doi: 10.1111/j.1476-5381.2011.01270.x.
8
Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism.基于内源性皮质醇代谢,使用三种不同参数评估人体中的CYP3A活性。
Acta Pharmacol Sin. 2009 Sep;30(9):1323-9. doi: 10.1038/aps.2009.116. Epub 2009 Aug 24.